Lantern Pharma Inc. (LTRN) Stock price, Description, News & Info

#Thinksabio latest news

Lantern Pharma’s Subsidiary, Starlight Therapeutics, Announces U.S. Food and Drug Administration Clearance of IND for Phase Ib/2a Glioblastoma Multiforme (GBM) Trial